Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abstract, aforementioned, Alabama, Alaska, Ampersand, Annex, antibody, APAC, ARA, Asia, assimilation, Atlanta, ATM, attach, attest, Avalon, Beacon, bedside, bench, biorepository, body, buy, CAGR, capability, capturing, CareFirst, cast, cater, CDC, cessation, CGI, chain, China, Chinese, clarifying, clean, companion, compounded, convince, CT, cytogenetic, decontamination, deep, deferral, denominator, directorship, disappointing, disinfect, disproportionate, distancing, Dodd, downturn, duration, dynamic, easily, Eastern, easy, EBITDA, effectuate, effectuation, eleven, ENDO, energy, England, episodically, Eric, esoteric, ethical, evolution, explaining, extraction, fight, filled, finite, Fisher, fka, flexibility, fluorescent, forgivable, forma, forty, fractional, frame, Fred, furloughed, furloughing, fusion, GA, gear, Genecast, germline, Gorman, headquarter, heart, hematological, hematology, holdback, hub, hybridization, hypothetical, ICON, Idaho, IHC, ill, Illumina, immune, immunohistochemistry, implicit, IMS, incentivize, Indemnitee, infection, Intermountain, inventory, irrevocable, Knechtel, KOL, Landmark, landscape, laying, leukemia, Lev, LIM, margin, Medica, merge, metabolism, metric, Michigan, Midwest, momentum, Morrisville, mRNA, NAACCR, NC, nearest, NGS, North, Northern, NWA, older, online, Oppenheimer, optimistic, OTCQB, Ourpharma, overestimating, Pacific, pandemic, Parexel, pari, Park, passu, Paycheck, perception, PhRMA, pool, PPP, precision, preferential, Premera, Probe, processor, procure, promptly, protein, purification, quantity, Raleigh, ramp, ratably, reaction, recapitalization, regime, rejection, remit, repurchase, resource, revolutionize, Robert, Roche, roll, ROU, RTP, Rutherford, safer, salesforce, SBA, scalable, SelectHealth, serological, serology, setup, seventy, shortfall, sinking, situation, sixty, slowdown, somatic, Southeastern, Southport, span, spread, standby, standpoint, steady, stratification, stricter, tailor, tailored, telecommunication, tender, Thermo, ThyGeNEXT®panel, toxicity, tracking, tranche, Triangle, unaudited, unconstitutional, undisclosed, unforgiven, unmet, unqualified, usable, vacancy, Vermont, Virginia, waiting, Washington, wearing, Wednesday, window, withheld
Removed:
accreted, accrue, agreeing, amounted, amounting, analyze, assured, carrier, centrally, chemical, clarity, clear, CMPO, complement, concurrent, confidentially, construction, deploy, distinguishing, divestiture, DOJ, enhancing, Equityholder, escalation, Excellence, excise, fix, format, fragmented, good, guaranteed, harder, inducement, introduction, maker, Maxim, measurable, moratorium, occupancy, outsourced, overallotment, path, pathological, people, persuasive, possession, predetermined, predictable, prepaid, privately, promised, promoted, QB, qualitative, quantitative, ready, reclassification, resolving, risky, robust, ruling, screening, separately, soft, stage, subtype, tenant, threatened, ThyGenX®and, treated, Trovagene, trustworthy, unamortized, underway, wind
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 EX-3.1
- 4.1 EX-4.1
- 4.9 EX-4.9
- 10.34 EX-10.34
- 10.36 EX-10.36
- 10.44 EX-10.44
- 10.45 EX-10.45
- 10.46 EX-10.46
- 10.47 EX-10.47
- 10.48 EX-10.48
- 10.49 EX-10.49
- 10.50 EX-10.50
- 10.51 EX-10.51
- 10.52 EX-10.52
- 10.53 EX-10.53
- 10.54 EX-10.54
- 10.55 EX-10.55
- 10.56 EX-10.56
- 10.57 EX-10.57
- 10.58 EX-10.58
- 10.59 EX-10.59
- 21.1 EX-21.1
- 23.1 EX-23.1
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
IDXG similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Interpace Biosciences, Inc.
Parsippany, New Jersey
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (Nos. 333-218140 and 333-218780), Form S-3 (Nos. 333-207263 and 333-227728) and Form S-8 (Nos. 333-61231, 333-60512, 333-177969, 333-201070, 333-214260, and 333-234284) of Interpace Biosciences Inc. of our report dated April 22, 2020, relating to the consolidated financial statements and financial statement schedule, which appears in this Form 10-K.
Woodbridge, New Jersey
April 22, 2020